Literature DB >> 19562675

Thyroid hormones induce cell proliferation and survival in ovarian granulosa cells COV434.

Cecilia Verga Falzacappa1, Claudia Mangialardo, Valentina Patriarca, Barbara Bucci, Donatella Amendola, Salvatore Raffa, Maria Rosaria Torrisi, Giuliana Silvestrini, Paola Ballanti, Giulia Moriggi, Antonio Stigliano, Ercole Brunetti, Vincenzo Toscano, Silvia Misiti.   

Abstract

Numerous evidences indicate that thyroid hormones exert an important role in the regulation of the reproductive system in the adult female. Although a clear demonstration of the thyroid-ovarian interaction is still lacking, it is conceivable that thyroid hormones might have a direct role in ovarian physiology via receptors in granulosa cells. In this study we analyzed if thyroid hormone treatment could affect cell proliferation and survival of COV434 cells. To this aim cell growth experiments and cell cycle analyses by flow cytometry were performed. Secondly the T(3) survival action was tested by TUNEL assay and MD30 cleavage analysis. We showed that T(3), and not T(4), can protect ovarian granulosa cells COV434 from apoptosis, regulating cell cycle and growth in the same cells. The increase in cell growth resulted in an augmented percentage of the cells in the S phase and, in a reduction of the doubling time (18%). Subsequently apoptotic pathway induced by serum deprivation has been evaluated in the cells exposed or not to thyroid hormone treatment. The T(3) treatment was able to remarkably counteract the apoptotic process. Even at the ultrastructural level there was an evident protective effect of T(3) in the cells that, besides the maintenance of the original morphology and, the absence of basophilic cytoplasm, conserved normal junctional areas. Furthermore, the protective T(3) effect evaluated by FACS analysis in the presence of a PI3K inhibitor revealed, as also confirmed by Western Blot on pAkt, that the PI3K pathway is crucial in T(3) survival action. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562675     DOI: 10.1002/jcp.21849

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Luteal expression of thyroid hormone receptors during gestation and postpartum in the rat.

Authors:  Paola B Navas; Analía L Redondo; F Darío Cuello-Carrión; Laura M Vargas Roig; Susana R Valdez; Graciela A Jahn; María B Hapon
Journal:  Thyroid       Date:  2014-06       Impact factor: 6.568

Review 2.  Thyroid hormones and tendon: current views and future perspectives. Concise review.

Authors:  Francesco Oliva; Anna C Berardi; Silvia Misiti; Nicola Maffulli
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

3.  Thyroid hormones act as mitogenic and pro survival factors in rat ovarian follicles.

Authors:  R Canipari; C Mangialardo; V Di Paolo; F Alfei; S Ucci; V Russi; M G Santaguida; C Virili; M Segni; S Misiti; M Centanni; C Verga Falzacappa
Journal:  J Endocrinol Invest       Date:  2018-06-22       Impact factor: 4.256

4.  Thyroid hormones enhance growth and counteract apoptosis in human tenocytes isolated from rotator cuff tendons.

Authors:  F Oliva; A C Berardi; S Misiti; C Verga Falzacappa; C V Falzacappa; A Iacone; N Maffulli
Journal:  Cell Death Dis       Date:  2013-07-04       Impact factor: 8.469

5.  Gamma Tocopherol Reduced Chemotherapeutic-Induced ROS in an Ovarian Granulosa Cell Line, But Not in Breast Cancer Cell Lines In Vitro.

Authors:  Daniela Figueroa Gonzalez; Fiona Young
Journal:  Antioxidants (Basel)       Date:  2020-01-07

6.  Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles.

Authors:  Federica Lopes; Rowena Smith; Richard A Anderson; Norah Spears
Journal:  Mol Hum Reprod       Date:  2014-07-30       Impact factor: 4.025

7.  Impact of Thyroid Autoimmunity on In Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes and Fetal Weight.

Authors:  Ning Huang; Lixue Chen; Ying Lian; Haining Wang; Rong Li; Jie Qiao; Hongbin Chi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-08       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.